ブラストサイジンS
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/05/13 10:46:21」(JST)
[Wiki en表示]
Blasticidin S |
|
IUPAC name
4-amino-1-[4-({(3S)-3-amino-5-[[amino(imino)methyl](methyl)amino]pentanoyl}amino)-2,3,4-trideoxy-β-D-erythro-hex-2-enopyranuronosyl]pyrimidin-2(1H)-one
|
Identifiers |
CAS number |
2079-00-7 Y |
PubChem |
258 |
ChemSpider |
148673 Y |
KEGG |
C02010 Y |
ChEMBL |
CHEMBL476894 Y |
Jmol-3D images |
Image 1 |
-
O=C1\N=C(\N)/C=C\N1[C@@H]\2O[C@H](C(=O)O)[C@H](/C=C/2)NC(=O)C[C@@H](N)CCN(C(=[N@H])N)C
|
-
InChI=1S/C17H26N8O5/c1-24(16(20)21)6-4-9(18)8-12(26)22-10-2-3-13(30-14(10)15(27)28)25-7-5-11(19)23-17(25)29/h2-3,5,7,9-10,13-14H,4,6,8,18H2,1H3,(H3,20,21)(H,22,26)(H,27,28)(H2,19,23,29)/t9-,10-,13+,14-/m0/s1 Y
Key: CXNPLSGKWMLZPZ-ZNIXKSQXSA-N Y
InChI=1/C17H26N8O5/c1-24(16(20)21)6-4-9(18)8-12(26)22-10-2-3-13(30-14(10)15(27)28)25-7-5-11(19)23-17(25)29/h2-3,5,7,9-10,13-14H,4,6,8,18H2,1H3,(H3,20,21)(H,22,26)(H,27,28)(H2,19,23,29)/t9-,10-,13+,14-/m0/s1
Key: CXNPLSGKWMLZPZ-ZNIXKSQXBS
|
Properties |
Molecular formula |
C17H26N8O5 |
Molar mass |
422.44 g mol−1 |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
Y (verify) (what is: Y/N?) |
Infobox references |
|
|
Blasticidin S is an antibiotic that is produced by Streptomyces griseochromogenes. In biological research, specifically genetic engineering, it is used to select transformed cells which have been engineered to carry a resistance gene for blasticidin. In short, DNA of interest is fused to DNA encoding a resistance gene, and then is transformed into cells. After allowing time for recovery and for cells to begin transcribing and translating their new DNA, blasticidin is added. Now only the cells that have the new DNA can grow.
Resistance genes
Three resistance genes have been cloned:
- bls (an acetyl transferase) from Streptoverticillum sp. which itself produces blasticidin in a natural example of biological warfare
- bsr (a blasticidin-S deaminase) from Bacillus cereus (other bsr genes are known as well, see listings in Genbank)
- BSD (another deaminase) from Aspergillus terreus
bsr and BSD are the most commonly used resistance genes. The proteins produced from these genes enable the cells carrying them to produce protein in the presence of blasticidin.
Mechanism of action
Blasticidin prevents the growth of both eukaryotic and prokaryotic cells. It works by inhibiting termination step of translation and peptide bond formation (to lesser extent) by the ribosome. This means that cells can no longer produce new proteins through translation of mRNA.
References
- blasticidin.com
- Taxonomy of Streptomyces griseochromogenes
English Journal
- The Protein Synthesis Inhibitor Blasticidin S Enters Mammalian Cells via Leucine-Rich Repeat-Containing Protein 8D.
- Lee CC1, Freinkman E, Sabatini DM, Ploegh HL.Author information 1MIT/Whitehead Institute, United States;AbstractLeucine-rich repeat-containing 8 (LRRC8) proteins have been identified as putative receptors involved in lymphocyte development and adipocyte differentiation. They remain poorly characterized and no specific function has been assigned to them. There is no consensus on how this family of proteins might function, because homology searches suggest that members of the LRRC8 family act not as plasma membrane receptors, but rather as channels that mediate cell-cell signaling. Here we provide experimental evidence that supports a role for LRRC8s in the transport of small molecules. We show that LRRC8D is a mammalian protein required for the import of the antibiotic blasticidin S. We characterize localization and topology of LRRC8A and LRRC8D and demonstrate that LRRC8D interacts with LRRC8A, LRRC8B, and LRRC8C. Given the suggested involvement in solute transport, our results support a model in which LRRC8s form one or more complexes that may mediate cell-cell communication by transporting small solutes.
- The Journal of biological chemistry.J Biol Chem.2014 Apr 29. [Epub ahead of print]
- Leucine-rich repeat-containing 8 (LRRC8) proteins have been identified as putative receptors involved in lymphocyte development and adipocyte differentiation. They remain poorly characterized and no specific function has been assigned to them. There is no consensus on how this family of proteins mig
- PMID 24782309
- Analysis of partial recombinants in lentiviral vector preparations.
- Kuate S1, Marino MP, Reiser J.Author information 1Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research , U.S. Food and Drug Administration, Bethesda, MD 20892.AbstractAbstract The presence of replication-competent lentivirus (RCL) in lentiviral vector preparations is a major safety concern for clinical applications of such vectors. RCL are believed to emerge from rare recombinant vector genomes that are referred to as partial recombinants or Psi-Gag recombinants. To quantitatively determine the fraction of partial recombinants in lentiviral vector preparations and to analyze them at the DNA sequence level, we established a drug selection assay involving a lentiviral packaging construct containing a drug-resistance gene encoding blasticidin (BSD) resistance. Upon transduction of target cells, the BSD resistance gene confers BSD resistance to the transduced cells. The results obtained indicate that there were up to 156 BSD-resistant colonies in a total of 10(6) transducing vector particles. The predicted recombination events were verified by polymerase chain reaction using genomic DNA obtained from BSD-resistant cell clones and by DNA sequence analysis. In an attempt to reduce the emergence of partial recombinants, sequence overlaps between the packaging and the vector constructs were reduced by substituting the Rev response element (RRE) present in the vector construct using a heterologous RRE element derived from simian immunodeficiency virus (SIVmac239). The results obtained showed that a reduction of sequence overlaps resulted in an up to sevenfold reduction of the frequency of BSD-resistant colonies, indicating that the capacity to form partial recombinants was diminished.
- Human gene therapy methods.Hum Gene Ther Methods.2014 Apr;25(2):126-35. doi: 10.1089/hgtb.2013.015. Epub 2014 Feb 14.
- Abstract The presence of replication-competent lentivirus (RCL) in lentiviral vector preparations is a major safety concern for clinical applications of such vectors. RCL are believed to emerge from rare recombinant vector genomes that are referred to as partial recombinants or Psi-Gag recombinants.
- PMID 24367910
- Site-specific DNA double-strand break generated by I-SceI endonuclease enhances ectopic homologous recombination in Pyricularia oryzae.
- Arazoe T1, Younomaru T, Ohsato S, Kimura M, Arie T, Kuwata S.Author information 1Graduate School of Agriculture, Meiji University, Kawasaki, Kanagawa, Japan.AbstractTo evaluate the contribution of DNA double-strand breaks (DSBs) to somatic homologous recombination (HR) in Pyricularia oryzae, we established a novel detection/selection system of DSBs-mediated ectopic HR. This system consists of donor and recipient nonfunctional yellow fluorescent protein (YFP)/blasticidin S deaminase (BSD) fusion genes and the yeast endonuclease I-SceI gene as a recipient-specific DSB inducer. The system enables to detect and select ectopic HR events by the restoration of YFP fluorescence and blasticidin S resistance. The transformed lines with donor and recipient showed low frequencies of endogenous ectopic HR (> 2.1%). Compared with spontaneous HR, c. 20-fold increases in HR and absolute frequency of HR as high as 40% were obtained by integration of I-SceI gene, indicating that I-SceI-mediated DSB was efficiently repaired via ectopic HR. Furthermore, to validate the impact of DSB on targeted gene replacement (TGR), the transformed lines with a recipient gene were transfected with an exogenous donor plasmid in combination with the DSB inducer. TGR events were not observed without the DSB inducer, whereas hundreds of colonies resulting from TGR events were obtained with the DSB inducer. These results clearly demonstrated that the introduction of site-specific DSB promotes ectopic HR repair in P. oryzae.
- FEMS microbiology letters.FEMS Microbiol Lett.2014 Mar;352(2):221-229. doi: 10.1111/1574-6968.12396. Epub 2014 Feb 26.
- To evaluate the contribution of DNA double-strand breaks (DSBs) to somatic homologous recombination (HR) in Pyricularia oryzae, we established a novel detection/selection system of DSBs-mediated ectopic HR. This system consists of donor and recipient nonfunctional yellow fluorescent protein (YFP)/bl
- PMID 24517488
Japanese Journal
- Transfection of Babesia bovis by Double Selection with WR99210 and Blasticidin-S and Its Application for Functional Analysis of Thioredoxin Peroxidase-1
- Doxycyclin誘導性HERC1およびHERC2同時発現抑制細胞株の樹立
- Doxycyclin誘導性ER<i><b>α</b></i>陽性BRCA1枯渇ヒト乳腺細胞の樹立
Related Links
- InvivoGen produces Blasticidin, an efficient selective antibiotic that acts on both eukaryotic and prokaryotic cells. Blasticidin is a peptidyl nucleoside antibiotic isolated from Streptomyces griseochromogenes that inhibits protein ...
- Blasticidin S はStreptomyces griseochromogenesから単離されたヌクレオシド系抗生物質で,原核細胞から真核細胞まで,広くそのタンパク質合成を阻害します。形質転換体を選択する際に有用です。 価格
★リンクテーブル★
[★]
- 英
- blasticidin
- 同
- ブラストサイジン、blasticidin
- 関
- ブラストサイジン中毒
参考
http://search.cosmobio.co.jp/cosmo_search_p/search_gate2/create_msds.asp?MAKER=CBC&HIN=203350&SIZE=%20%20%20%20%2025&CD=01115&CON=%8C%B4%91%CC&CMP=1
http://ja.wikipedia.org/wiki/%E3%83%96%E3%83%A9%E3%82%B9%E3%83%88%E3%82%B5%E3%82%A4%E3%82%B8%E3%83%B3S